The performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB).
Vertex licenses Editas’ gene editing technology in $100m deal – Pharmaceutical Technology
Share this article Vertex will pay $50m to Editas upfront, with an additional contingent $50m payment. Image credit: Shutterstock/Catalin Rusnac. Vertex Pharmaceuticals has entered a